Friends, colleagues and professional societies have all shared loving tributes to the veteran electrophysiologist, who died at the age of 69. 

However, the popular anti-inflammatory drug was linked to at least one other clinical benefit cardiologists should know about. 

Anne Kroman, DO, PhD, noted that early, aggressive treatment is critical when EP leads need to be removed. 

The two devices, already approved by the FDA, were designed with batteries expected to last more than 15 years. 

“We identified a problem in cardiology,” one cardiologist explained. “Heart imaging has made remarkable progress in recent decades, but the electrics of the heart have eluded us."

"The PulseSelect PFA system ushers the EP community to a new era of safe, effective and efficient AF ablation that overcomes many challenges in our current practice," said Amin Al-Ahmad, MD, St. David's Medical Center in Austin, Texas. 

Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

The new study included data on patients who presented for TAVR with preexisting AFib as well as those who developed new-onset AFib after the procedure.